# Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects

> **NCT00978614** · PHASE1 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 126 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Neramexane

## Key facts

- **NCT ID:** NCT00978614
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2011-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978614, "Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00978614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*